AMBROSINO, Paolo
 Distribuzione geografica
Continente #
EU - Europa 2.445
NA - Nord America 2.391
AS - Asia 898
SA - Sud America 202
AF - Africa 93
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 7
Totale 6.044
Nazione #
US - Stati Uniti d'America 2.335
RU - Federazione Russa 1.297
IE - Irlanda 311
SG - Singapore 310
CN - Cina 269
BR - Brasile 155
DE - Germania 118
IT - Italia 114
FI - Finlandia 93
AT - Austria 87
UA - Ucraina 81
GB - Regno Unito 80
VN - Vietnam 79
SE - Svezia 71
IN - India 64
FR - Francia 62
CI - Costa d'Avorio 60
BE - Belgio 46
HK - Hong Kong 40
CA - Canada 36
PL - Polonia 31
AR - Argentina 21
JP - Giappone 19
BD - Bangladesh 15
MX - Messico 15
ES - Italia 14
IQ - Iraq 14
NL - Olanda 14
ZA - Sudafrica 13
ID - Indonesia 12
IR - Iran 10
TR - Turchia 9
EC - Ecuador 7
LT - Lituania 7
AU - Australia 6
CO - Colombia 6
PK - Pakistan 6
EU - Europa 5
IL - Israele 5
JO - Giordania 5
KZ - Kazakistan 5
MA - Marocco 5
MY - Malesia 5
PH - Filippine 5
CL - Cile 4
KR - Corea 4
PY - Paraguay 4
DO - Repubblica Dominicana 3
GR - Grecia 3
KE - Kenya 3
RS - Serbia 3
SA - Arabia Saudita 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
CH - Svizzera 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
DZ - Algeria 2
KG - Kirghizistan 2
LB - Libano 2
LK - Sri Lanka 2
LV - Lettonia 2
NZ - Nuova Zelanda 2
RO - Romania 2
SN - Senegal 2
TN - Tunisia 2
VE - Venezuela 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AZ - Azerbaigian 1
BO - Bolivia 1
CR - Costa Rica 1
ET - Etiopia 1
GE - Georgia 1
GF - Guiana Francese 1
GM - Gambi 1
HN - Honduras 1
KW - Kuwait 1
MD - Moldavia 1
ML - Mali 1
MU - Mauritius 1
NG - Nigeria 1
NP - Nepal 1
OM - Oman 1
PS - Palestinian Territory 1
TG - Togo 1
TH - Thailandia 1
TM - Turkmenistan 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.044
Città #
Dallas 505
Moscow 425
Dublin 308
Chandler 240
San Jose 185
Jacksonville 171
Singapore 150
Ashburn 117
Beijing 105
New York 94
Ann Arbor 92
Vienna 82
Helsinki 78
Abidjan 60
The Dalles 47
Woodbridge 47
Brussels 46
Wilmington 45
Frankfurt am Main 42
Hong Kong 40
Los Angeles 40
San Mateo 33
Lauterbourg 29
Boardman 28
Princeton 28
Ho Chi Minh City 25
Warsaw 25
Rome 24
Dearborn 22
Chennai 21
São Paulo 20
Orem 19
Tokyo 17
Molise 16
Poplar 15
Hillsboro 14
Houston 14
London 14
Columbus 13
Hanoi 13
Stockholm 12
Da Nang 11
San Francisco 11
Toronto 11
Hefei 10
Montreal 10
Nanjing 10
Johannesburg 9
Kunming 9
Redwood City 9
Boston 8
Brooklyn 8
Chicago 8
Mexico City 8
Mumbai 8
Munich 8
Naples 8
Phoenix 8
Baghdad 7
Jakarta 7
Santa Clara 7
Amsterdam 6
Ankara 6
Augusta 6
Council Bluffs 6
Denver 6
Falkenstein 6
Manchester 6
Mountain View 6
Napoli 6
Norwalk 6
Amman 5
Atlanta 5
Calgary 5
Curitiba 5
Lahore 5
New Delhi 5
Nuremberg 5
Pune 5
Quito 5
Seattle 5
Wuhan 5
Brasília 4
Buenos Aires 4
City of London 4
Clearwater 4
Milan 4
Ottawa 4
Porto Alegre 4
Roseto Degli Abruzzi 4
Sacramento 4
Shenyang 4
Athens 3
Baotou 3
Belgrade 3
Bexley 3
Charlotte 3
Dhaka 3
Gaillimh 3
Haiphong 3
Totale 3.675
Nome #
Activation of Kv7 potassium channels inhibits intracellular Ca2+ increases triggered by TRPV1-mediated pain-inducing stimuli in F11 immortalized sensory neurons 281
Epilepsy-causing mutations in kv7.2 c-terminus affect binding and functional modulation by calmodulin. 219
Characterization of two de novo KCNT1 mutations in children with malignant migrating partial seizures in infancy 209
Pharmacological Targeting Of Neuronal Kv7.2/3 Channels: A Focus On Chemotypes And Receptor Sites 207
Effects of natural and synthetic isothiocyanate-based H2S-releasers against chemotherapy-induced neuropathic pain: Role of Kv7 potassium channels 204
Molecular pathophysiology and pharmacology of the voltage-sensing module of neuronal ion channels 203
Early-Onset Epileptic Encephalopathy Caused by Gain-of-Function Mutations in the Voltage Sensor of Kv7.2 and Kv7.3 Potassium Channel Subunits. 200
Epileptic encephalopathy in a patientwith a novel variant in the Kv7.2 S2 transmembrane segment: Clinical, genetic, and functional features 198
Expression and function of Kv7.4 channels in Rat cardiac mitochondria: possible targets for cardioprotection 198
A novel homozygous KCNQ3 loss-of-function variant causes non-syndromic intellectual disability and neonatal-onset pharmacodependent epilepsy 197
Early-onset epileptic encephalopathy caused by a reduced sensitivity of Kv7.2 potassium channels to phosphatidylinositol 4,5-bisphosphate 195
Differential Regulation of PI(4,5)P2Sensitivity of Kv7.2 and Kv7.3 Channels by Calmodulin 192
Early Treatment with Quinidine in 2 Patients with Epilepsy of Infancy with Migrating Focal Seizures (EIMFS) Due to Gain-of-Function KCNT1 Mutations: Functional Studies, Clinical Responses, and Critical Issues for Personalized Therapy 191
De novo gain-of-function variants in KCNT2 as a novel cause of developmental and epileptic encephalopathy 189
Calcium cytotoxicity sensitizes prostate cancer cells to standard-of-care treatments for locally advanced tumors 177
Identification of a Potent Tryptophan-Based TRPM8 Antagonist with in Vivo Analgesic Activity 175
Infantile spasms and encephalopathy without preceding neonatal seizures caused by KCNQ2 R198Q, a gain-of-function variant 172
β-Adrenergic response is counteracted by extremely-low-frequency pulsed electromagnetic fields in beating cardiomyocytes 162
Neutralization of a unique, negatively-charged residue in the voltage sensor of K(V)7.2 subunits in a sporadic case of benign familial neonatal seizures 159
Neuronal potassium channel openers in the management of epilepsy: role and potential of retigabine 158
Kv7.3 Compound Heterozygous Variants in Early Onset Encephalopathy Reveal Additive Contribution of C-Terminal Residues to PIP2-Dependent K+Channel Gating 151
Tryptamine-Based Derivatives as Transient Receptor Potential Melastatin Type 8 (TRPM8) Channel Modulators 149
A novel KCNC1 gain-of-function variant causing developmental and epileptic encephalopathy: "Precision medicine" approach with fluoxetine 147
Gabapentin treatment in a patient with KCNQ2 developmental epileptic encephalopathy 147
Erratum to: Towards the realization of label-free biosensors through impedance spectroscopy integrated with IDES technology 146
Kv7.4 channels regulate potassium permeability in neuronal mitochondria 146
KCNQ2 R144 variants cause neurodevelopmental disability with language impairment and autistic features without neonatal seizures through a gain-of-function mechanism 138
Epileptic channelopathies caused by neuronal Kv7 (KCNQ) channel dysfunction 137
Functional Characterization of Two Variants at the Intron 6-Exon 7 Boundary of the KCNQ2 Potassium Channel Gene Causing Distinct Epileptic Phenotypes 135
De novo variants in KCNA3 cause developmental and epileptic encephalopathy 135
Gain of function due to increased opening probability by two KCNQ5 pore variants causing developmental and epileptic encephalopathy 129
Case report: Marked electroclinical improvement by fluoxetine treatment in a patient with KCNT1-related drug-resistant focal epilepsy 127
Fluoxetine Treatment in Epilepsy of Infancy with Migrating Focal Seizures Due to KCNT1 Variants: An Open Label Study. 117
In Silico Assisted Identification, Synthesis, and In Vitro Pharmacological Characterization of Potent and Selective Blockers of the Epilepsy-Associated KCNT1 Channel 108
KCNT2-Related Disorders: Phenotypes, Functional, and Pharmacological Properties 101
Synthesis and Pharmacological Characterization of Conformationally Restricted Retigabine Analogues as Novel Neuronal Kv7 Channel Activators 100
Pharmacological approaches in drug-resistant pediatric epilepsies caused by pathogenic variants in potassium channel genes. 81
Long-Term Survival of Methotrexate as First-Line Therapy in Rheumatoid Arthritis, Psoriatic Arthritis and Undifferentiated Arthritis 79
Totale 6.159
Categoria #
all - tutte 23.682
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.682


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202147 0 0 0 0 0 0 0 0 0 5 38 4
2021/2022209 4 29 1 8 22 14 7 18 42 26 22 16
2022/2023886 116 50 6 101 65 78 1 37 377 31 18 6
2023/2024220 36 27 9 3 5 68 5 6 10 5 7 39
2024/2025700 67 20 93 26 149 18 36 24 81 16 75 95
2025/20263.214 107 328 349 267 919 613 235 109 116 171 0 0
Totale 6.159